https://www.selleckchem.com/pr....oducts/sirpiglenasta
nderlying mechanism may be related to the improved levels of the immune indicator CD3 T cells. Significant reductions in the negative conversion time of fecal nucleic acid and the duration of negative conversion of pharyngeal-fecal nucleic acid were identified in the treatment group as compared to the control group, illustrating the potential therapeutic benefits of using TRQC as a complement to conventional medicine in patients with mild and moderate COVID-19. The underlying mechanism may be related to the improved levels of the
Like
Comment
Share
